Azepines
- Name
- Azepines
- Accession Number
- DBCAT001304
- Description
Seven membered heterocyclic rings containing a NITROGEN atom.
- Drugs
Drug Drug Description Quetiapine A psychotropic agent used for the management of bipolar disorder, schizophrenia, and major depressive disorder. Meptazinol Not Annotated Dilazep Not Annotated Pentetrazol A cough suppressant. Omapatrilat For the treatment of hypertension. Paratoulene phosphate Not Available TAK-475 Investigated for use/treatment in hyperlipidemia. Temocapril Temocapril is an ACE inhibitor primarily indicated in the treatment of hypertension and congestive heart failure, diabetic nephropathy, and improvement of prognosis for coronary artery diseases (including acute myocardial infarction). Tianeptine An atypical tricyclic antidepressant with antidepressant and anxiolytic effects primarily used to treat major depressive disorder. GSK-2330672 GSK2330672 has been investigated for the treatment of Diabetes Mellitus, Type 2. Taselisib Taselisib has been used in trials studying the treatment and basic science of LYMPHOMA, Breast Cancer, Ovarian Cancer, Solid Neoplasm, and HER2/Neu Negative, among others. Piclozotan Piclozotan has been investigated for the treatment of Parkinson's Disease. Eleclazine Eleclazine has been used in trials studying the treatment of LQT2 Syndrome, Long QT Syndrome, Ischemic Heart Disease, Ventricular Arrhythmia, and Long QT Syndrome Type 3, among others. Elobixibat Elobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation. PF-04620110 PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects). Ziresovir Ziresovir is under investigation in clinical trial NCT03699202 (Anti-RSV Study in Chinese Patients (ASCENT)). Brensocatib Brensocatib is under investigation in clinical trial NCT03218917 (Assessment of INS1007 in Subjects With Non-cystic Fibrosis Bronchiectasis). Lapaquistat Lapaquistat is under investigation in clinical trial NCT00256178 (Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.). - Drugs & Drug Targets